Advertisement
ResearchIn-Press PreviewGeneticsNeuroscience
Open Access |
10.1172/JCI200890
1Laboratory of Biochemistry and Immunology, The University of Osaka, Suita, Japan
2Department of Cellular and Molecular Pharmacology, Juntendo University, Tokyo, Japan
3Department of Cellular and Neuropathology, Juntendo University, Tokyo, Japan
Find articles by Lin, X. in: PubMed | Google Scholar
1Laboratory of Biochemistry and Immunology, The University of Osaka, Suita, Japan
2Department of Cellular and Molecular Pharmacology, Juntendo University, Tokyo, Japan
3Department of Cellular and Neuropathology, Juntendo University, Tokyo, Japan
Find articles by Ryoden, Y. in: PubMed | Google Scholar
1Laboratory of Biochemistry and Immunology, The University of Osaka, Suita, Japan
2Department of Cellular and Molecular Pharmacology, Juntendo University, Tokyo, Japan
3Department of Cellular and Neuropathology, Juntendo University, Tokyo, Japan
Find articles by Suzuki, C. in: PubMed | Google Scholar
1Laboratory of Biochemistry and Immunology, The University of Osaka, Suita, Japan
2Department of Cellular and Molecular Pharmacology, Juntendo University, Tokyo, Japan
3Department of Cellular and Neuropathology, Juntendo University, Tokyo, Japan
Find articles by Ishikawa, H. in: PubMed | Google Scholar
1Laboratory of Biochemistry and Immunology, The University of Osaka, Suita, Japan
2Department of Cellular and Molecular Pharmacology, Juntendo University, Tokyo, Japan
3Department of Cellular and Neuropathology, Juntendo University, Tokyo, Japan
Find articles by Sakuragi, T. in: PubMed | Google Scholar
1Laboratory of Biochemistry and Immunology, The University of Osaka, Suita, Japan
2Department of Cellular and Molecular Pharmacology, Juntendo University, Tokyo, Japan
3Department of Cellular and Neuropathology, Juntendo University, Tokyo, Japan
Find articles by Uchiyama, Y. in: PubMed | Google Scholar
1Laboratory of Biochemistry and Immunology, The University of Osaka, Suita, Japan
2Department of Cellular and Molecular Pharmacology, Juntendo University, Tokyo, Japan
3Department of Cellular and Neuropathology, Juntendo University, Tokyo, Japan
Find articles by
Nagata, S.
in:
PubMed
|
Google Scholar
|
Published March 24, 2026 - More info
VPS13A is an intracellular lipid transfer protein comprising over 3,000 amino acids. Mutations in human VPS13A cause VPS13A disease, a neurodegenerative disorder that affects movement and cognition. VPS13A forms a complex with the membrane protein XK to mediate ATP-induced phospholipid scrambling in the plasma membrane. Here, we established a mouse cell system expressing full-length mouse VPS13A and examined its interaction with XK. Mutational analysis revealed that VPS13A binds to XK through a C-terminal β-strand that interacts with a β-hairpin in the central region of XK, an interaction essential for scramblase activity. The XK paralog XKR2, which contains a similar β-hairpin structure, also associates with VPS13A and supports phospholipid scrambling. We analyzed ten mouse VPS13A variants corresponding to patient mutations and classified them into four groups: (1) L67P, I90K, and W2453R, which showed reduced expression; (2) A1091P and M3080R, which were normally expressed but lacked scramblase activity; (3) S1446P, Q2689H, Y2713C, and R3084H, which modestly impaired expression or activity; and (4) I2763R, which altered cell size, and disrupted ER independently of XK. These findings define the VPS13A–XK interaction interface, clarify the functional impact of disease-causing mutations, and reveal an unexpected gain-of-function mutation of a VPS13A variant.